RXST

RxSight, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-11.3M
ExitQ1 2026
$11M
--
$5.62
Steven CohenPoint72
$4.5M733.3k shares
TrimQ1 2026
$8.3M
$6.16
$5.62
Baillie GiffordInvestor
$4.3M690.3k shares
TrimQ1 2026
$3.0M
$6.16
$5.62
Paul Tudor Jones IITudor Investment
$930k151k shares
AddQ1 2026
$729k
$6.16
$5.62
Ken GriffinCitadel Advisors
$11M1.1M shares
ExitQ4 2025
$12M
$10.42
$5.62
Steven CohenPoint72
$13M1.2M shares
AddQ4 2025
$11M
$10.42
$5.62

News

globenewswire.comRxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forumglobenewswire.comMay 19seekingalpha.comRxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 13seekingalpha.comRxSight, Inc. (RXST) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 9zacks.comRxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 6globenewswire.comRxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlookglobenewswire.comMay 6